The Latest Cardiac and Vascular News
LOS ALTOS, Calif., Nov. 26, 2018 /PRNewswire/ — HeartVista, a pioneer in AI-driven autonomous MRI solutions, announced today its AI-driven, One-Click Autonomous MRI acquisition software for cardiac exams. Integrated with existing MRI scanners, the software uses Artificial Intelligence to guide image acquisition. With a single click, MRI technologists can perform a cardiac ischemia […]
SAN FRANCISCO, Nov. 21, 2018 /PRNewswire/ — Arterys, the leader in intelligent, 100% web-based medical imaging software, will demonstrate its wide-ranging suite of AI powered solutions that support fast, efficient and accurate analysis of medical images at RSNA 2018 (North Hall, Booth 7964), November 25-30 in Chicago. Driven by deep learning and cloud computation, the Arterys […]
MARLBOROUGH, Mass., Nov. 20, 2018 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc. (LSE: BTG), a company headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well […]
VANCOUVER, British Columbia–(BUSINESS WIRE)–According to a new series of reports by iData Research, the United States cardiac surgery device market is valued at $5.7 billion USD and is forecast to exceed $10 billion by 2024. The largest segment of the cardiac surgery market is the transcatheter heart valve replacement (THVR) […]
NEW HOPE, Pa., Nov. 20, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address major unmet medical needs, today announced that David Hochman, Chairman and Chief Executive Officer, will present a corporate overview at the Piper Jaffray Healthcare […]
IRVINE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, announced today that it has received an update from INVIMA (the Colombian equivalent of the U.S. FDA) in Bogota on the status of […]
DUBLIN – November 20, 2018 – Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2019, which ended October 26, 2018. The company reported second quarter worldwide revenue of $7.481 billion, an increase of 6.1 percent as reported or 7.5 percent on an organic basis, […]
Santa Monica, CA, Nov. 20, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company’s Founder, Chairman & CEO Kenneth Londoner is making […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today honored four innovators of aortic therapy at the 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium®), a meeting of endovascular specialists highlighting developments in the treatment of vascular disease. At an […]
MELBOURNE, Australia and NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) — Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today reported strong financial results and provided operational highlights for the first quarter ended September 30, 2018. Key financial results for the three months ended September 30, 2018 (first quarter FY2019) Significant increase in revenues to […]
